Marc Beer – article recap
Marc Beer is spearheading the release of several new pelvic floor products under his new startup, Renovia Inc. These products were developed for bladder incontinence and a number of other pelvic floor disorders that affect women. Renovia’s first product, Leva, received approval from the FDA in April. Leva contains sensor technology that allows the user to see the position of their pelvic floor muscles and is designed as a pelvic floor strengthening system. Leva is only one of the products Renovia plans to offer for women’s therapeutic and diagnostic needs. This startup has received a number of notable backers, including The Longwood Fund, Perceptive Advisors and Missouri-Based Ascension Ventures. Together with his co-founders Ramon Iglesias, MD and Yolanda Lorié, Beer’s company will begin the development of four new therapeutic and diagnostic products. Based in Boston, Renovia will be closing a $32 million Series B round, with $10 million in venture debt. This money will go towards financing clinical trials, product and corporate development, and future commercial launches.
Marc Beer has been utilizing his expertise in the biotechnology, pharmaceutical, device, and diagnostic industries for over 25 years. Marc has a number of companies he can boast on his resume, including ViaCell, Erytech Pharma, Genzyme, and Abbott Laboratories. The companies Beer has worked for over the years have placed an emphasis on servicing individuals with rare diseases and genetic disorders. Beer’s commitment to providing products that improve the lives of millions with debilitating illness shows through in his past endeavors.
Pelvic floor dysfunction can affect a number of regions in your body, including the bladder, rectum, and the uterus. This dysfunction can cause issues with bowel movements, sexual intercourse, and even cause long-term colon damage. Developing a team with a thorough understanding of these issues was essential to Renovia’s success. A few of people recruited for this startup include Jessica McKinney-Director of The Center for Pelvic and Women’s Health for Marathon Physical Therapy & Sports, and Medicine, and Dr. Samantha Pulliam-Assistant Professor of Obstetrics and Gynecology. Their expertise, combined with Beer’s experience in biotechnology, stand as a testament to the efficiency of their product. Learn more: https://www.fiercebiotech.com/medtech/renovia-raises-42m-to-fund-digital-health-solutions-for-pelvic-floor-strengthening